These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17264798)

  • 1. Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro.
    Tanimoto K; Kaneyasu M; Shimokuni T; Hiyama K; Nishiyama M
    Pharmacogenet Genomics; 2007 Jan; 17(1):1-10. PubMed ID: 17264798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients.
    Sai K; Saito Y; Tatewaki N; Hosokawa M; Kaniwa N; Nishimaki-Mogami T; Naito M; Sawada J; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Tamura T; Yamada Y; Ohe Y; Yoshida T; Minami H; Ohtsu A; Matsumura Y; Saijo N; Okuda H
    Br J Clin Pharmacol; 2010 Aug; 70(2):222-33. PubMed ID: 20653675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes.
    Fukami T; Nakajima M; Maruichi T; Takahashi S; Takamiya M; Aoki Y; McLeod HL; Yokoi T
    Pharmacogenet Genomics; 2008 Oct; 18(10):911-20. PubMed ID: 18794728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.
    Sanghani SP; Quinney SK; Fredenburg TB; Davis WI; Murry DJ; Bosron WF
    Drug Metab Dispos; 2004 May; 32(5):505-11. PubMed ID: 15100172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.
    Sanghani SP; Quinney SK; Fredenburg TB; Sun Z; Davis WI; Murry DJ; Cummings OW; Seitz DE; Bosron WF
    Clin Cancer Res; 2003 Oct; 9(13):4983-91. PubMed ID: 14581373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes.
    Hosokawa M; Furihata T; Yaginuma Y; Yamamoto N; Watanabe N; Tsukada E; Ohhata Y; Kobayashi K; Satoh T; Chiba K
    Drug Metab Pharmacokinet; 2008; 23(1):73-84. PubMed ID: 18305377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-prodrug systems: carboxylesterase/CPT-11.
    Danks MK; Potter PM
    Methods Mol Med; 2004; 90():247-62. PubMed ID: 14657567
    [No Abstract]   [Full Text] [Related]  

  • 8. A discriminative analytical method for detection of CES1A1 and CES1A2/CES1A3 genetic variants.
    Zhu HJ; Brinda B; Froehlich TE; Markowitz JS
    Pharmacogenet Genomics; 2012 Mar; 22(3):215-8. PubMed ID: 22237548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of CPT-11 resistance of lung cancer cells by adenovirus-mediated gene transfer of the human carboxylesterase cDNA.
    Kojima A; Hackett NR; Crystal RG
    Cancer Res; 1998 Oct; 58(19):4368-74. PubMed ID: 9766666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.
    Danks MK; Morton CL; Krull EJ; Cheshire PJ; Richmond LB; Naeve CW; Pawlik CA; Houghton PJ; Potter PM
    Clin Cancer Res; 1999 Apr; 5(4):917-24. PubMed ID: 10213229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors.
    Kojima A; Hackett NR; Ohwada A; Crystal RG
    J Clin Invest; 1998 Apr; 101(8):1789-96. PubMed ID: 9541511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.
    Humerickhouse R; Lohrbach K; Li L; Bosron WF; Dolan ME
    Cancer Res; 2000 Mar; 60(5):1189-92. PubMed ID: 10728672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel procedure with improved resolution and specificity for amplification and differentiation of variants of the gene encoding carboxylesterase 1.
    Bjerre D; Rasmussen HB;
    Pharmacogenet Genomics; 2017 Apr; 27(4):155-158. PubMed ID: 28146010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan.
    Uchino J; Takayama K; Harada A; Sone T; Harada T; Curiel DT; Kuroki M; Nakanishi Y
    Cancer Gene Ther; 2008 Feb; 15(2):94-100. PubMed ID: 18157147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions.
    Slatter JG; Su P; Sams JP; Schaaf LJ; Wienkers LC
    Drug Metab Dispos; 1997 Oct; 25(10):1157-64. PubMed ID: 9321519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted and tumour targeted human carboxylesterase for activation of irinotecan.
    Oosterhoff D; Pinedo HM; van der Meulen IH; de Graaf M; Sone T; Kruyt FA; van Beusechem VW; Haisma HJ; Gerritsen WR
    Br J Cancer; 2002 Sep; 87(6):659-64. PubMed ID: 12237777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxylesterase 1A2 encoding gene with increased transcription and potential rapid drug metabolism in Asian populations.
    Rasmussen HB; Madsen MB; Lyauk YK; Hansen PR; Hughes T;
    Drug Metab Pers Ther; 2017 Sep; 32(3):163-168. PubMed ID: 28803225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11.
    Oosterhoff D; Overmeer RM; de Graaf M; van der Meulen IH; Giaccone G; van Beusechem VW; Haisma HJ; Pinedo HM; Gerritsen WR
    Br J Cancer; 2005 Mar; 92(5):882-7. PubMed ID: 15756257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
    Merali Z; Ross S; Paré G
    Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11.
    Wierdl M; Tsurkan L; Hyatt JL; Edwards CC; Hatfield MJ; Morton CL; Houghton PJ; Danks MK; Redinbo MR; Potter PM
    Cancer Gene Ther; 2008 Mar; 15(3):183-92. PubMed ID: 18188187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.